Dabigatran Recall

Mar 28 2023

George Fritsma

Thanks to Dave McGlasson for forwarding this Medscape bulletin [click] announcing Ascend Laboratories’ recall of 10 dabigatran lots due to the detection of the nitrosamine impurity, N-nitroso-dabigatran, a potential carcinogen.

Comments (0)

Anticoagulant Therapy

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Leave a Reply Cancel reply

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question